AI Article Synopsis
- The study evaluated clinical and hemodynamic outcomes in 55 patients who received the LivaNova Crown PRT aortic prosthesis, with follow-up lasting up to one year.
- A total of 55 patients, mostly elderly, underwent aortic valve replacement, showing preserved left ventricular function in many cases and no in-hospital deaths, but some experienced complications like atrial fibrillation and stroke.
- After an average follow-up period, the prosthesis maintained satisfactory hemodynamic performance, with a significant majority of patients reporting improved functional status and a notable reduction in left ventricular mass.
Article Abstract
Background: Currently, only limited data are available on the rate of hemodynamic progression with clinical outcome in patients receiving the latest Crown PRT aortic prosthesis. The study aim was to report clinical and hemodynamic outcomes in 55 consecutive patients for a follow up of up to one year after Crown PRT implantation.
Methods: Between February and September 2015, a total of 55 patients (34 males, 21 females; mean age 77.3 ± 1.2 years) underwent aortic valve replacement (AVR) with the latest LivaNova Crown PRT bioprosthesis at the authors' institution. Left ventricular function was preserved in 79% of patients. Data relating to the patients' clinical, echocardiographic and functional capacities were obtained prospectively.
Results: There were no in-hospital deaths. Significant perioperative complications included stroke (3.6%), atrial fibrillation (27%), and permanent pacemaker insertion (1.8%). Pre-discharge echocardiography demonstrated peak (PG) and mean (MG) transprosthetic gradients of 24.4 ± 10.4 mmHg and 12.9 ± 6.2 mmHg, respectively. The Doppler velocity index (DVI) was 0.49 ± 0.13, and the effective orifice area index (EOAi) 0.89 ± 0.12 cm2/m2. At a mean follow up of 1.3 ± 0.3 years, the transprosthetic gradients, DVI and EOAi were not significantly different from postoperative or pre-discharge values. The patients' NYHA status was I or II in 95% of cases, and the mean left ventricular mass had decreased by 36% at the end of follow up.
Conclusions: The Crown PRT is an effective bioprosthesis, with a low incidence of valve-related complications comparable to those of other current bioprostheses. The bioprosthesis demonstrated satisfactory results in terms of hemodynamics and freedom from reoperation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
5-Year haemodynamic performance of three aortic bioprostheses. A randomized clinical trial.
Eur J Cardiothorac Surg
August 2023
Department of Cardiovascular Surgery, Clínico San Carlos Hospital, Madrid, Spain.
Objectives: The Carpentier Perimount (CP) Magna Ease, the Crown Phospholipid Reduction Treatment (PRT) and the Trifecta bovine pericardial valves have been widely used worldwide. The primary end point of this study was to compare the haemodynamic performance quantified by in vivo echocardiograms of these 3 aortic prostheses.
Methods: The "BEST-VALVE" (comparison of 3 contemporary cardiac bioprostheses: mid-term valve haemodynamic performance) was a single-centre randomized clinical trial to compare the haemodynamic and clinical outcomes of the aforementioned bioprostheses.
Perceval S, sutureless aortic valve: cost-consequence analysis.
Kardiochir Torakochirurgia Pol
March 2022
MBA - Health Department of Economics, National and Kapodistrian University of Athens, Athens, Greece.
Introduction: Sutureless aortic valve prostheses have the potential of shortening ischemic time.
Aim: We conducted the present study to assess the clinical and economic impact of the biological, sutureless, self-expanding Perceval S valve since the effect of shortened operative times on hospital costs remains unclear.
Material And Methods: This is a retrospective analysis.
four-dimensional flow magnetic resonance analysis of the effect of pericardial valve design on aortic flow.
J Med Eng Technol
April 2022
Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Article Synopsis
- The study examined how different designs of bioprosthetic pericardial valves affect fluid flow patterns using advanced 4D Flow magnetic resonance imaging.
- Three commercially available valves (Trifecta, Carpentier-Edwards PERIMOUNT Magna, Crown PRT®) were tested under steady flow conditions, focusing on the smallest comparable sizes.
- Results showed that the Trifecta valve had the best flow characteristics, including the lowest peak velocity and optimal effective orifice area (EOA), whereas the Magna and Crown valves displayed less efficient flow profiles.
One-Year Hemodynamic Performance of Three Cardiac Aortic Bioprostheses: A Randomized Comparative Clinical Trial.
J Clin Med
November 2021
Department of Cardiac Surgery, Cardiovascular Institute, Hospital Clínico San Carlos, 28940 Madrid, Spain.
Background: We aimed to compare 1 year the hemodynamic in-vivo performance of three biological aortic prostheses (Carpentier Perimount Magna Ease, Crown PRT, and Trifecta).
Methods: The sample used in this study comes from the "BEST-VALVE" clinical trial, which is a phase IV single-blinded randomized clinical trial with the three above-mentioned prostheses.
Results: 154 patients were included.
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial.
JAMA Psychiatry
January 2022
Department of Psychology and Neuroscience, University of Colorado, Boulder.
Importance: Chronic back pain (CBP) is a leading cause of disability, and treatment is often ineffective. Approximately 85% of cases are primary CBP, for which peripheral etiology cannot be identified, and maintenance factors include fear, avoidance, and beliefs that pain indicates injury.
Objective: To test whether a psychological treatment (pain reprocessing therapy [PRT]) aiming to shift patients' beliefs about the causes and threat value of pain provides substantial and durable pain relief from primary CBP and to investigate treatment mechanisms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!